Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.

Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Abstract Text:

    k takeuchiK Takeuchi,a tanakaA Tanaka,r ohnoR Ohno,a yokotaA Yokota,k takeuchiK Takeuchi,a tanakaA Tanaka,r ohnoR Ohno,a yokotaA Yokota,

    Nonsteroidal antiinflammatory drugs (NSAIDs) such as indomethacin decrease mucosal PGE(2) production by inhibiting cyclooxygenase (COX) activity and produce damage in the small intestine. The development of intestinal lesions as induced by indomethacin was accompanied by increases in intestinal motility, enterobacterial invasion, and myeloperoxidase (MPO) as well as inducible nitric oxide synthase (iNOS) activity, together with the up-regulation of COX-2 and iNOS mRNA expression. Neither the selective COX-1 inhibitor, SC-560, nor the selective COX-2 inhibitor, rofecoxib, alone caused intestinal damage, but their combined administration produced lesions. SC-560, but not rofecoxib, caused intestinal hypermotility, bacterial invasion and the expression of COX-2 as well as iNOS mRNAs, yet the iNOS and MPO activity was increased only when rofecoxib was administered together with SC-560. Although SC-560 inhibited the PG production, the level of PGE(2) was recovered, in a rofecoxib-dependent manner. The intestinal hypermotility response to indomethacin was prevented by both 16,16-dimethyl PGE(2) and atropine but not ampicillin, yet all these agents inhibited not only the bacterial invasion but also the expression of COX-2 as well as the iNOS activity in the intestinal mucosa following indomethacin treatment, resulting in preventing the intestinal lesions. These results suggest that inhibition of COX-1, despite causing intestinal hypermotility, bacterial invasion and iNOS expression, up-regulates the expression of COX-2, and the PGE(2) derived from COX-2 counteracts deleterious events caused by COX-1 inhibition and maintains the mucosal integrity. These sequences of events explain why intestinal damage occurs when both COX-1 and COX-2 are inhibited.

    Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Publishing Authors By Initials

    k takeuchiK Takeuchi,a tanakaA Tanaka,r ohnoR Ohno,a yokotaA Yokota,k takeuchiK Takeuchi,a tanakaA Tanaka,r ohnoR Ohno,a yokotaA Yokota,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Journal of physiology and pharmacology : an offici

    VOLUME: 54 Suppl 4

    Page Numbers: 165-82

    Journal Abbreviation: J. Physiol. Pharmacol.

    ISSN: 0867-5910

    DAY: 12

    MONTH: Dec

    YEAR: 2003

    Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9114501

    Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.

    AFFILIATION: Department of Pharmacology and Experimental Therapeutics Kyoto Pharmaceutical University, Misasagi, Yamashina, Kyoto, Japan. takeuchi@mb.kyoto-phu.ac.jp

    Country: Poland

    Poland Research PublicationPoland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Physiol Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News